Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_assertion type Assertion NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_head.
- NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_provenance.
- NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_assertion evidence source_evidence_literature NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_provenance.
- NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_assertion SIO_000772 19148529 NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_provenance.
- NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_assertion wasDerivedFrom lhgdn-20090331 NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_provenance.
- NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_assertion wasGeneratedBy ECO_0000203 NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_provenance.